SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Babe Didrikson Zaharias — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMildred Ella Didrikson Zaharias
Date of birth1911-06-26
IdentifiersMRN HR-ML038-SYN-TD; SSN (made up) 000-38-4471
Document date1953-06-01
AuthorRosalind Vasquez-Thornbury, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Cough, sore throat and a low fever for three days, on immunotherapy. [S]

History of Present Illness

Ms. Didrikson Zaharias called the oncology line three days into a cough and was seen the same day. She had three doses of dostarlimab, the last two weeks ago, and cycle 4 is due in a week. The illness began with a scratchy throat and a runny nose after a tournament week in which several players in the locker room had colds. She now has a dry cough, worse at night, and a temperature up to 37.9 °C at home. She is not short of breath, even climbing the slope to the eighteenth green, and has no chest pain. She has no diarrhea, rash, or abdominal pain, and her bowel movements have been normal since the second dose, with no blood. She has felt more tired than usual for about two weeks, before the cold began. She is practicing but skipped yesterday's round. She has had no thoughts of self-harm. [S]

ElementDetail
OnsetThree days ago, after colds among players at a tournament
SeverityDry cough, worse at night; temperature up to 37.9 °C; not short of breath
ContextThree doses of dostarlimab; a new cough on PD-1 blockade must prompt a check for pneumonitis
Associated signs and symptomsRunny nose and sore throat; tired for two weeks; no diarrhea, rash or chest pain

Review of Systems

SystemResultFinding
ConstitutionalPositiveLow fever; tired for about two weeks, before the cold began
Ears, nose, mouth, and throatPositiveSore throat and runny nose
RespiratoryPositiveDry cough; no breathlessness on exertion, wheeze or blood in the sputum
CardiovascularNegativeNo chest pain, palpitations or leg swelling
GastrointestinalNegativeBowel movements normal; no blood, diarrhea or abdominal pain
IntegumentaryNegativeNo rash or itching
EndocrineNegativeNo cold intolerance, weight change or thirst
PsychiatricNegativeAnnoyed at missing a round; no thoughts of self-harm

8 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other morningOne tablet every other morningOral route1953-03-30activeS
Dostarlimab-gxly 50 mg/mL injection, 500 mg intravenously over 30 minutes every 3 weeks, for nine doses (six months)500 mg every 3 weeks for nine dosesIntravenous route1953-04-06 to 1953-09-21completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1953-06-01Body height168cmS
1953-06-01Body weight63kgS
1953-06-01Body mass index (BMI) [Ratio]22.3kg/m2S
1953-06-01Systolic blood pressure114mm[Hg]S
1953-06-01Diastolic blood pressure70mm[Hg]S
1953-06-01Heart rate88/minS
1953-06-01Respiratory rate16/minS
1953-06-01Body temperature37.9CelS
1953-06-01Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1953-06-01Hemoglobin [Mass/volume] in Blood12.6g/dL12-15.5 g/dLNormalS
1953-06-01Leukocytes [#/volume] in Blood by Automated count9.410*3/uL4-11 10*3/uLNormalS
1953-06-01Platelets [#/volume] in Blood by Automated count29010*3/uL150-400 10*3/uLNormalS
1953-06-01Thyrotropin [Units/volume] in Serum or Plasma5.8m[IU]/L0.45-4.5 mIU/LHighS
1953-06-01Thyroxine (T4) free [Mass/volume] in Serum or Plasma1ng/dL0.8-1.8 ng/dLNormalS

Physical Exam

Vital signs recorded on 1953-06-01; see the Vital Signs section. [S]

SystemFinding
GeneralWell, talking in full sentences; temperature 37.9 °C; weight 63.0 kg
Vital signsOxygen saturation 98% at rest and 97% after a brisk walk along the corridor; respiratory rate 16
Head, eyes, ears, nose, and throatPharynx red without exudate; nasal congestion; no sinus tenderness; ear drums normal
NeckSmall tender anterior cervical nodes; thyroid not enlarged or tender
RespiratoryClear to auscultation bilaterally; no crackles or wheeze
SkinNo rash

Problems

ProblemClinical statusVerificationCodeProvenance
Bright red blood with bowel movements for about three months, with narrower stools, urgency, a feeling of incomplete emptying, and a firm, ulcerated mass felt on the back wall of the lower rectum at about 5 cm from the anal verge: a rectal cancer must be confirmed or excluded. Colonoscopy with biopsy booked this weekresolvedconfirmed K62.5S — Synthetic presenting problem anchored to the documented fatigue before her cancer diagnosis. Superseded by the diagnosis at the second visit.
Iron deficiency anemia from chronic rectal blood loss: hemoglobin 11.0 g/dL, MCV 77 fL, ferritin 9 ng/mL, with tirednessactiveconfirmed D50.0S — Synthetic finding anchored to the documented fatigue at the end of the 1952 season.
Adenocarcinoma of the low rectum, mismatch repair deficient (loss of MSH2 and MSH6; microsatellite instability high), cT3bN1M0 (stage IIIB) on pelvic MRI, lower edge 4 cm from the anal verge and about 1 cm above the anorectal junction, mesorectal fascia clear, no extramural venous invasion; CEA 5.8 ng/mL; synthetic modern detail linked to her documented cancer, whose site the sources do not record exactlyactiveconfirmed C20S — Synthetic histology, site, stage, mismatch repair status and course; the sources say she had cancer treated with a colostomy and call it colon cancer (R on the site). See sources.md.
Acute viral upper respiratory infection with cough and sore throat, a week before cycle 4 of dostarlimab; oxygen saturation and chest X-ray normal, so immune-related pneumonitis is unlikely; rapid influenza and COVID-19 tests negative; resolvedactiveconfirmed J06.9S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer (current version); summarized in Benson AB, et al. NCCN Guidelines Insights: Rectal Cancer, Version 3.2024. J Natl Compr Canc Netw 2024;22(6):366-375 (PMID 39151454) (2026); Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392) (2021)

Follow-up: Cycle 4 in one week if afebrile. Restaging and review at cycle 5. Call for breathlessness, chest pain, diarrhea, rash or high fever. Next scheduled visit 1953-06-29: restaging after four doses: pelvic MRI and endoscopy, immune-related hypothyroidism, and the decision to continue PD-1 blockade. [S]